DK233088A - Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum - Google Patents

Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum

Info

Publication number
DK233088A
DK233088A DK233088A DK233088A DK233088A DK 233088 A DK233088 A DK 233088A DK 233088 A DK233088 A DK 233088A DK 233088 A DK233088 A DK 233088A DK 233088 A DK233088 A DK 233088A
Authority
DK
Denmark
Prior art keywords
peptid
pharmaceutical
protected
manufacture
acceptable salts
Prior art date
Application number
DK233088A
Other languages
English (en)
Other versions
DK233088D0 (da
Inventor
Wolfgang Koenig
Peter Schindler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK233088D0 publication Critical patent/DK233088D0/da
Publication of DK233088A publication Critical patent/DK233088A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK233088A 1987-04-29 1988-04-28 Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum DK233088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3714277 1987-04-29

Publications (2)

Publication Number Publication Date
DK233088D0 DK233088D0 (da) 1988-04-28
DK233088A true DK233088A (da) 1988-10-30

Family

ID=6326516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233088A DK233088A (da) 1987-04-29 1988-04-28 Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum

Country Status (8)

Country Link
EP (1) EP0288965A2 (da)
JP (1) JPS63284197A (da)
KR (1) KR880012640A (da)
AU (1) AU1526388A (da)
DK (1) DK233088A (da)
IL (1) IL86195A0 (da)
PT (1) PT87350B (da)
ZA (1) ZA883033B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK15888D0 (da) * 1988-01-14 1988-01-14 Carlsberg Biotechnology Ltd Enzymatisk fremgangsmaade til fremstilling af immunmodulerende pentapeptider samt mellemprodukter til brug ved fremgangsmaaden
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
US5376640A (en) * 1989-12-25 1994-12-27 Nisshin Flour Milling Co., Ltd. Lipolytic enzyme inhibitors
GB2239455B (en) * 1989-12-25 1993-12-15 Nisshin Flour Milling Co Formulations of lipolytic enzyme inhibitors and use of said inhibitors
JP2960947B2 (ja) * 1989-12-25 1999-10-12 日清製粉株式会社 脂質分解酵素阻害剤
DE69229173T2 (de) * 1991-07-04 1999-09-16 Garvan Inst Med Res Pla2 hemmende verbindungen
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
KR100241643B1 (ko) 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
WO1996039385A1 (en) 1995-06-06 1996-12-12 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
MX9709875A (es) * 1995-06-06 1998-03-31 Pfizer N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas.
WO1998007718A1 (en) 1996-08-22 1998-02-26 Warner-Lambert Company Non-peptide bombesin receptor antagonists
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
WO1999043334A1 (en) * 1998-02-24 1999-09-02 Tatjana Piljac Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
WO2001098540A2 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Recombination modulators and methods for their production and use
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite

Also Published As

Publication number Publication date
DK233088D0 (da) 1988-04-28
PT87350A (pt) 1988-05-01
KR880012640A (ko) 1988-11-28
AU1526388A (en) 1988-11-03
ZA883033B (en) 1988-11-01
JPS63284197A (ja) 1988-11-21
PT87350B (pt) 1992-08-31
EP0288965A2 (de) 1988-11-02
IL86195A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
DK233088D0 (da) Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum
DK304488A (da) Borholdige peptider eller fysiologisk acceptable salte deraf og deres anvendelse samt mellemprodukter til dens fremstilling
NO873298L (no) Oralt terapeutisk system med systematisk virkning.
NO892834D0 (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK143588D0 (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK209188D0 (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DK55088A (da) 3,4-dihydro-2h-benzo(b)pyraner, deres fremstilling og anvendelse som laegemidler
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK166214C (da) Gnrh-antagonistisk peptid og farmaceutisk acceptable salte heraf samt farmaceutisk praeparat indeholdende peptidet
DK366888D0 (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK69389A (da) Renin-haemmende aminosyrederivater og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
NO892744D0 (no) N-terminale aminodiol-aminosyrederivater og fremgangsmaatefor deres fremstilling.
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK543788D0 (da) Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK421389A (da) Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK42888A (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
DK47788D0 (da) 14,15-substituerede lanosteroler og fysiologisk acceptable salte deraf og deres anvendelse som farmaceutika
DK238786A (da) Bicycliske aminosyrer eller fysiologiske uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til fremstillingen og disses fremstilling
DK238089D0 (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn